Guinta-ason, Glen .
HRN: 27-20-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
CEFUROXIME 750MG (VIAL)
05/26/2025
06/02/2025
IV
750mg
Q8
PCAP; UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractPneumoniaBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes